Uses and Limitations of Portal Vein Embolization for Improving Perioperative Outcomes in Hepatocellular Carcinoma

Mark J. Truty, Jean Nicolas Vauthey

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Hepatic resection remains the only curative option for the majority of patients with hepatocellular carcinoma (HCC) who do not meet criteria for transplantation or local ablative options. As the majority of patients with HCC also have underlying chronic liver disease and cirrhosis, post-hepatectomy complications can be significant, and in some prohibitive. The technique of portal vein embolization (PVE) has evolved to increase the candidacy of patients for major hepatectomy, as well as improve postoperative outcomes and safety. This review will focus on PVE and discuss our institution's experience with uses and limitations of this technique for HCC.

Original languageEnglish (US)
Pages (from-to)102-109
Number of pages8
JournalSeminars in oncology
Volume37
Issue number2
DOIs
StatePublished - Apr 2010

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Uses and Limitations of Portal Vein Embolization for Improving Perioperative Outcomes in Hepatocellular Carcinoma'. Together they form a unique fingerprint.

Cite this